慢性疾病之间与药物相关的负担变化:基于人口的横截面调查
Heidi Mikkola1,2, Emma Aarnio3, Katri Hämeen-Anttila3
1Finnish Medicines Agency (Fimea), Helsinki, Finland. heidi.mikkola@fimea.fi.
BMC health services research
|October 2, 2025
概括
药物相关负担 (MRB) 影响了近一半患有慢性疾病的成年人. 糖尿病,心脏病和类风湿性疾病显著增加了经历这种负担的可能性.
科学领域:
- 药物经济学 药物经济学
- 公共卫生 公共卫生
- 老年学是一门学科.
背景情况:
- 药物治疗对于治疗慢性疾病至关重要.
- 管理药物的患者可能会经历与药物相关的负担 (MRB).
- 在不同的慢性疾病中,MRB的差异很大.
研究的目的:
- 检查不同慢性疾病中与药物相关负担 (MRB) 的变化.
- 为了确定与成人人口中较高MRB相关的特定慢性疾病.
主要方法:
- 芬兰成年人 (18-79岁) 的2021年在线基于人口的横截面调查.
- 使用基于"患者与药物生活经验" (PLEM) 模型的13项仪器测量MRB.
- 经社会人口统计学和健康变量调整后的物流回归分析.
主要成果:
- 在2081名受访者中,1323人患有慢性病并使用处方药;43.5%的人报告MRB.
- 糖尿病 (OR 1.77),心脏病 (OR 1.53) 和类风湿性疾病 (OR 1.42) 与MRB相关.
- 与医疗保健相关的药物负担和药物不良反应是MRB的主要原因.
结论:
- 与药物相关的负担 (MRB) 在患有慢性疾病的个体中很普遍,患病率因疾病而异.
- 糖尿病,心脏病和类风湿性疾病与MRB增加有关.
- 识别高风险状况允许有针对性的医疗保健资源分配和干预计划.
相关概念视频
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
Dosage Regimens: Designs and Approaches
263
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
263
Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Drug Dosage Regimen: Overview
4.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.4K
Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
Dosage Regimens: Partial Pharmacokinetic Parameters
154
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
154

